{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:02:14Z","timestamp":1770822134431,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,4,21]],"date-time":"2003-04-21T00:00:00Z","timestamp":1050883200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2003,4,21]],"date-time":"2003-04-21T00:00:00Z","timestamp":1050883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1038\/ng1151","type":"journal-article","created":{"date-parts":[[2003,4,29]],"date-time":"2003-04-29T18:07:32Z","timestamp":1051639652000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":196,"title":["Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells"],"prefix":"10.1038","volume":"34","author":[{"given":"Meyling H.","family":"Cheok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Downing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayton W.","family":"Naeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary V.","family":"Relling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,4,21]]},"reference":[{"key":"BFng1151_CR1","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1056\/NEJM199808273390907","volume":"339","author":"CH Pui","year":"1998","unstructured":"Pui, C.H. & Evans, W.E. Acute lymphoblastic leukemia. N. Engl. J. Med. 339, 605\u2013615 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFng1151_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1126\/science.286.5439.487","volume":"286","author":"WE Evans","year":"1999","unstructured":"Evans, W.E. & Relling, M.V. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 286, 487\u2013491 (1999).","journal-title":"Science"},{"key":"BFng1151_CR3","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1056\/NEJMra020526","volume":"348","author":"WE Evans","year":"2003","unstructured":"Evans, W.E. & McLeod, H.L. Pharmacogenomics\u2014drug disposition, drug targets, and side effects. N. Engl. J. Med. 348, 538\u2013549 (2003).","journal-title":"N. Engl. J. Med."},{"key":"BFng1151_CR4","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1470-2045(01)00516-2","volume":"2","author":"CH Pui","year":"2001","unstructured":"Pui, C.H., Campana, D. & Evans, W.E. Childhood acute lymphoblastic leukaemia\u2014current status and future perspectives. Lancet Oncol. 2, 597\u2013607 (2001).","journal-title":"Lancet Oncol."},{"key":"BFng1151_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1126\/science.286.5439.531","volume":"286","author":"TR Golub","year":"1999","unstructured":"Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531\u2013537 (1999).","journal-title":"Science"},{"key":"BFng1151_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng765","volume":"30","author":"SA Armstrong","year":"2002","unstructured":"Armstrong, S.A. et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat. Genet. 30, 41\u201347 (2002).","journal-title":"Nat. Genet."},{"key":"BFng1151_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando, A.A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75\u201387 (2002).","journal-title":"Cancer Cell"},{"key":"BFng1151_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1535-6108(02)00032-6","volume":"1","author":"E-J Yeoh","year":"2002","unstructured":"Yeoh, E.-J. et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1, 133\u2013143 (2002).","journal-title":"Cancer Cell"},{"key":"BFng1151_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/73439","volume":"24","author":"U Scherf","year":"2000","unstructured":"Scherf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24, 236\u2013244 (2000).","journal-title":"Nat. Genet."},{"key":"BFng1151_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0925-5710(97)00583-5","volume":"66","author":"M Tsurusawa","year":"1997","unstructured":"Tsurusawa, M., Saeki, K. & Fujimoto, T. Differential induction of apoptosis on human lymphoblastic leukemia Nalm-6 and Molt-4 cells by various antitumor drugs. Int. J. Hematol. 66, 79\u201388 (1997).","journal-title":"Int. J. Hematol."},{"key":"BFng1151_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1126\/science.2649979","volume":"244","author":"GB Elion","year":"1989","unstructured":"Elion, G.B. The purine path to chemotherapy. Science 244, 41\u201347 (1989).","journal-title":"Science"},{"key":"BFng1151_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25\u201329 (2000).","journal-title":"Nat. Genet."},{"key":"BFng1151_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35043058","volume":"1","author":"MB Kastan","year":"2000","unstructured":"Kastan, M.B. & Lim, D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1, 179\u2013186 (2000).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng1151_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/387516a0","volume":"387","author":"R Baskaran","year":"1997","unstructured":"Baskaran, R. et al. Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation. Nature 387, 516\u2013519 (1997).","journal-title":"Nature"},{"key":"BFng1151_CR15","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.1073\/pnas.81.18.5694","volume":"81","author":"JC Li","year":"1984","unstructured":"Li, J.C. & Kaminskas, E. Accumulation of DNA strand breaks and methotrexate cytotoxicity. Proc. Natl. Acad. Sci. USA 81, 5694\u20135698 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng1151_CR16","first-page":"2036","volume":"48","author":"A Lorico","year":"1988","unstructured":"Lorico, A. et al. Accumulation of DNA strand breaks in cells exposed to methotrexate or N10-propargyl-5,8-dideazafolic acid. Cancer Res. 48, 2036\u20132041 (1988).","journal-title":"Cancer Res."},{"key":"BFng1151_CR17","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1128\/MCB.14.3.1815","volume":"14","author":"WG Nelson","year":"1994","unstructured":"Nelson, W.G. & Kastan, M.B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell Biol. 14, 1815\u20131823 (1994).","journal-title":"Mol. Cell Biol."},{"key":"BFng1151_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist, C.J. & Kastan, M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421, 499\u2013506 (2003).","journal-title":"Nature"},{"key":"BFng1151_CR19","first-page":"300","volume":"58","author":"J Wijnen","year":"1996","unstructured":"Wijnen, J. et al. Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15\u201316. Am. J. Hum. Genet. 58, 300\u2013307 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng1151_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0959-8049(98)00031-8","volume":"34","author":"R Palmirotta","year":"1998","unstructured":"Palmirotta, R. et al. Transcripts with splicings of exons 15 and 16 of the hMLH1 gene in normal lymphocytes: implications in RNA-based mutation screening of hereditary non-polyposis colorectal cancer. Eur. J. Cancer 34, 927\u2013930 (1998).","journal-title":"Eur. J. Cancer"},{"key":"BFng1151_CR21","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/21690","volume":"399","author":"JG Gong","year":"1999","unstructured":"Gong, J.G. et al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399, 806\u2013809 (1999).","journal-title":"Nature"},{"key":"BFng1151_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","volume":"273","author":"PF Swann","year":"1996","unstructured":"Swann, P.F. et al. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 273, 1109\u20131111 (1996).","journal-title":"Science"},{"key":"BFng1151_CR23","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/3282","volume":"4","author":"MJ Marton","year":"1998","unstructured":"Marton, M.J. et al. Drug target validation and identification of secondary drug target effects using DNA microarrays. Nat. Med. 4, 1293\u20131301 (1998).","journal-title":"Nat. Med."},{"key":"BFng1151_CR24","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/bcr433","volume":"4","author":"C Sotiriou","year":"2002","unstructured":"Sotiriou, C. et al. Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer. Breast Cancer Res. 4, R3 (2002).","journal-title":"Breast Cancer Res."},{"key":"BFng1151_CR25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/0006-2952(93)90045-X","volume":"45","author":"JP Bokkerink","year":"1993","unstructured":"Bokkerink, J.P. et al. 6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts. Biochem. Pharmacol. 45, 1455\u20131463 (1993).","journal-title":"Biochem. Pharmacol."},{"key":"BFng1151_CR26","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","volume":"335","author":"R Gorlick","year":"1996","unstructured":"Gorlick, R. et al. Intrinsic and acquired resistance to methotrexate in acute leukemia. N. Engl. J. Med. 335, 1041\u20131048 (1996).","journal-title":"N. Engl. J. Med."},{"key":"BFng1151_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI118409","volume":"97","author":"E Masson","year":"1996","unstructured":"Masson, E. et al. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J. Clin. Invest. 97, 73\u201380 (1996).","journal-title":"J. Clin. Invest."},{"key":"BFng1151_CR28","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1172\/JCI117552","volume":"94","author":"TW Synold","year":"1994","unstructured":"Synold, T.W. et al. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. J. Clin. Invest. 94, 1996\u20132001 (1994).","journal-title":"J. Clin. Invest."},{"key":"BFng1151_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/4447","volume":"21","author":"RJ Lipshutz","year":"1999","unstructured":"Lipshutz, R.J., Fodor, S.P., Gingeras, T.R. & Lockhart, D.J. High density synthetic oligonucleotide arrays. Nat. Genet. 21, 20\u201324 (1999).","journal-title":"Nat. Genet."}],"updated-by":[{"DOI":"10.1038\/ng0603-231b","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000}}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng1151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1151","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng1151.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:18:14Z","timestamp":1684444694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng1151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4,21]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["BFng1151"],"URL":"https:\/\/doi.org\/10.1038\/ng1151","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4,21]]},"assertion":[{"value":"6 January 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}